Evidence-based guidelines for the management of hypertension in children with chronic kidney disease

Area of Science:

• Pediatric Nephrology
• Cardiovascular Health
• Clinical Practice Guidelines

Background:

• Hypertension is prevalent in pediatric chronic kidney disease (CKD) and is a significant risk factor for renal and cardiovascular complications.
• Existing clinical practice guidelines (e.g., 4th Task Force, ESH, NKF KDOQI, KDIGO) offer recommendations for managing hypertension in pediatric CKD.
• Limited pediatric trial evidence contributes to discrepancies among these guidelines, potentially causing inconsistent clinical care.

Purpose of the Study:

• To critically review the evidence supporting current clinical practice guideline recommendations for blood pressure management in children with CKD.
• To analyze discrepancies in recommendations for blood pressure assessment, treatment targets, and first-line antihypertensive medications.
• To emphasize the importance of understanding the evidence base beyond summary statements for optimal clinical decision-making.

Main Methods:

• Systematic review of existing clinical practice guidelines for pediatric hypertension in CKD.
• Analysis of the strength of evidence underpinning recommendations on blood pressure assessment, targets, and pharmacotherapy.
• Comparative evaluation of guideline discrepancies and their potential impact on clinical practice.

Main Results:

• Identified variations in blood pressure targets and treatment strategies across major pediatric CKD guidelines.
• Highlighted the limited pediatric-specific evidence base as a primary driver of these discrepancies.
• Emphasized the need for careful interpretation of guideline recommendations in light of the underlying evidence.

Conclusions:

• Discrepancies in pediatric CKD hypertension guidelines necessitate careful clinical judgment.
• Clinicians should critically evaluate the evidence supporting guideline recommendations to ensure optimal patient care.
• Further pediatric research is crucial to reduce practice variation and improve outcomes for children with CKD and hypertension.